TRAINLINE PLC
TRANSACTIONS IN OWN SECURITIES
Trainline plc ("Trainline") announces today that it has purchased the following number of its ordinary shares of
Ordinary Shares
Date of purchase: |
11 December 2024 |
Number of ordinary shares purchased: |
155,975 |
Highest price paid per share: |
432.00p |
Lowest price paid per share: |
416.80p |
Volume weighted average price paid per share: |
426.34p |
The purchased shares will be cancelled.
Following the purchase of these shares, the remaining number of ordinary shares in issue will be 451,638,412. Trainline does not hold any ordinary shares in Treasury. The figure of 451,638,412 may be used by shareholders (and others with notification obligations) as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the
http://www.rns-pdf.londonstockexchange.com/rns/7587P_1-2024-12-11.pdf
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
Enquiries
For investor enquiries, Andrew Gillian investors@trainline.com
For media enquiries, Hollie Conway press@trainline.com
Brunswick Group
Simone Selzer trainline@brunswickgroup.com / +44 207 404 5959
About Trainline
Trainline (www.trainline.com) is the leading independent rail and coach travel platform selling rail and coach tickets to millions of travellers worldwide, enabling them to seamlessly search, book and manage their journeys all in one place via its highly rated website and mobile app. Trainline is a one‐stop shop for rail and coach travel bringing together millions of routes, fares and journey times from rail and coach carriers across
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.